Oppenheimer Asset Management Inc. Castle Biosciences Inc Transaction History

Oppenheimer Asset Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$16.0 - $45.99 $79,824 - $229,444	-4,989 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$33.17 - $46.98 $165,485 - $234,383	4,989 New	4,989 $223,000
Q4 2021 Feb 02, 2022	SELL	$39.06 - $67.58 $170,848 - $295,594	-4,374 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$60.13 - $77.6 $4,810 - $6,208	-80 Reduced 1.8%	4,374 $291,000
Q2 2021 Aug 03, 2021	BUY	$50.07 - $76.78 $3,955 - $6,065	79 Added 1.81%	4,454 $326,000
Q1 2021 May 17, 2021	BUY	$58.92 - $97.33 $257,775 - $425,818	4,375 New	4,375 $300,000

210

26.6M

128K

35.4K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $677M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.